Bitrue is adding a new sector-tracking futures contract to its derivatives platform, offering exposure to XLV, the Health Care Select Sector SPDR Fund. Trading opened August 17 at 12:00 UTC, with the exchange offering up to 20x leverage on the contract.
XLV tracks a basket of large-cap U.S. healthcare names spanning pharmaceuticals, biotechnology, medical devices and healthcare services. The underlying fund manages roughly $42 billion in assets, with its largest holdings concentrated in a handful of major drugmakers — Eli Lilly, Johnson & Johnson, AbbVie, UnitedHealth Group and Merck together account for close to half the fund's weighting.
Part of a Wider Push Into Sector ETF Derivatives
The listing extends Bitrue's lineup of stock- and sector-linked perpetual products beyond individual equities and into broad sector baskets, letting traders take a single leveraged position on the healthcare sector as a whole rather than picking individual pharmaceutical or biotech names. That approach mirrors a wider trend among centralized exchanges, which have been rapidly expanding their menus of synthetic, crypto-native products tracking traditional-market benchmarks as demand for round-the-clock access to equity exposure grows.
Related: Ondo's Tokenized Stock Platform Tops $1B TVL as Binance Grabs Off-Hours Trade
Why Healthcare, and Why Now
Healthcare has been a comparatively defensive sector for equity investors this year, with steady demand for pharmaceutical and biotech names even as other parts of the market have swung more sharply on macro and rate expectations. Offering leveraged access to that sector through a crypto-native futures contract gives traders a way to express a healthcare view — bullish or bearish — without needing a traditional brokerage account or waiting for regular market hours to open. As with Bitrue's other equity-linked contracts, the XLV futures product settles based on the underlying ETF's price, giving the exchange's derivatives desk another instrument in what has become an increasingly crowded race among exchanges to offer tokenized and synthetic access to Wall Street.
